{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:55:38Z","timestamp":1793105738770,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/2(17 )\/CD\/2021 - NCD -II"],"award-info":[{"award-number":["3\/1\/2(17 )\/CD\/2021 - NCD -II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/PR22126\/BRB\/10\/1585\/2017"],"award-info":[{"award-number":["BT\/PR22126\/BRB\/10\/1585\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004843","name":"Manipal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["CRG \/ 2021\/003804"],"award-info":[{"award-number":["CRG \/ 2021\/003804"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bioorg.2024.107689","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T03:04:04Z","timestamp":1722567844000},"page":"107689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Targeting next-generation PDE4 inhibitors in search of potential management of rheumatoid arthritis and psoriasis"],"prefix":"10.1016","volume":"151","author":[{"given":"Harshavardhan","family":"Bhuktar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Thirupataiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guntipally","family":"Mounika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snigdha","family":"Samarpita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arulkumaran","family":"Rithvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.V.S.","family":"Sasi Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roumi","family":"Naskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavender","family":"Medishetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.C.","family":"Jagadish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore V.L.","family":"Parsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahaboobkhan","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandipan","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manojit","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107689_b0005","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41577-021-00603-1","article-title":"Immune-mediated inflammatory disease therapeutics: past, present and future","volume":"21","author":"McInnes","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioorg.2024.107689_b0010","first-page":"973","article-title":"Immune-mediated diseases from the point of view of psychoneuroimmunoendocrinology","volume":"11","author":"Ortega","year":"2022","journal-title":"Biology (Basel)"},{"issue":"suppl 10","key":"10.1016\/j.bioorg.2024.107689_b0015","article-title":"Immune-mediated inflammatory diseases (IMID) collectively rank among the leading causes of death","volume":"71","author":"Wu","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bioorg.2024.107689_b0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3899\/jrheum.110901","article-title":"Socioeconomic burden of immune-mediated inflammatory diseases - focusing on work productivity and disability","volume":"88","author":"Jacobs","year":"2011","journal-title":"J. Rheumatol. Suppl."},{"key":"10.1016\/j.bioorg.2024.107689_b0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000493390","article-title":"Rheumatoid arthritis: A brief overview of the treatment","volume":"27","author":"Bullock","year":"2019","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.bioorg.2024.107689_b0030","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107689_b0035","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.3390\/molecules27154964","article-title":"An overview of PDE4 inhibitors in clinical trials: 2010 to early 2022","volume":"27","author":"Crocetti","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107689_b0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12916-023-03049-5","article-title":"Incidence of immune-mediated inflammatory diseases following COVID-19: A matched cohort study in UK primary care","volume":"21","author":"Syed","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.bioorg.2024.107689_b0045","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/odi.12275","article-title":"Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets","volume":"21","author":"Ahmad","year":"2015","journal-title":"Oral Dis."},{"key":"10.1016\/j.bioorg.2024.107689_b0050","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/1744666X.2023.2219897","article-title":"Topical roflumilast for the treatment of psoriasis","volume":"19","author":"Drakos","year":"2023","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.bioorg.2024.107689_b0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1759720X10381432","article-title":"Apremilast: A novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases","volume":"2","author":"Schette","year":"2010","journal-title":"Ther. Adv. Musculoskeletal Dis."},{"key":"10.1016\/j.bioorg.2024.107689_b0060","unstructured":"L.A. Gharat, G. Balasubramanian, N. Khairatkar-Joshi, Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders, 2006 WO 2006\/064355 A2."},{"key":"10.1016\/j.bioorg.2024.107689_b0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pupt.2008.01.009","article-title":"MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers","volume":"21","author":"Boot","year":"2008","journal-title":"Pulm. Pharmacol. Ther."},{"key":"#cr-split#-10.1016\/j.bioorg.2024.107689_b0070.1","doi-asserted-by":"crossref","unstructured":"a) B. Purushothaman, P. Arumugam, G. Kulsi, J.M. Song, Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis, Eur. J. Med. Chem. 145 (2018) 673-690","DOI":"10.1016\/j.ejmech.2017.12.069"},{"key":"#cr-split#-10.1016\/j.bioorg.2024.107689_b0070.2","doi-asserted-by":"crossref","unstructured":"b) A.F. Donnell, P.J. Dollings, J.A. Butera, A.J. Dietrich, K.K. Lipinski, A. Ghavami, W.D. Hirst, Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors. Bioorg. Med. Chem. Lett. 20 (2010) 2163-2167","DOI":"10.1016\/j.bmcl.2010.02.044"},{"key":"#cr-split#-10.1016\/j.bioorg.2024.107689_b0070.3","doi-asserted-by":"crossref","unstructured":"c) K. Naganuma, A. Omura, N. Maekawara, M. Saitoh, N. Ohkawa, T. Kubota, H. Nagumo, T. Kodama, M. Takemura, Y. Ohtsuka, J. Nakamura, R. Tsujita, K. Kawasaki, H. Yokoi, M. Kawanishi, Discovery of selective PDE4B inhibitors, Bioorg. Med. Chem. Lett.19 (2009) 3174-3176","DOI":"10.1016\/j.bmcl.2009.04.121"},{"key":"#cr-split#-10.1016\/j.bioorg.2024.107689_b0070.4","doi-asserted-by":"crossref","unstructured":"d) M. Kranz, M. Wall, B. Evans, A. Miah, S. Ballantine, C. Delves, B. Dombroski, J. Gross, J. Schneck, J.P. Villa, M. Neu, D.O. Somers, Identification of PDE4B over 4D subtype-selective inhibitors revealing an unprecedented binding mode, Bioorg. Med. Chem. 17 (2009) 5336-5341","DOI":"10.1016\/j.bmc.2009.03.061"},{"key":"#cr-split#-10.1016\/j.bioorg.2024.107689_b0070.5","doi-asserted-by":"crossref","unstructured":"e) D.R. Gorja, S. Mukherjee, C.L.T. Meda, G.S. Deora, K.L. Kumar, A. Jain, G.H. Chaudhari, K.S. Chennubhotla, R.K. Banote, P. Kulkarni, K.V.L. Parsa, K. Mukkanti, M. Pal, Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors, Org. Biomol. Chem. 11 (2013) 2075-2079","DOI":"10.1039\/c3ob27424a"},{"key":"#cr-split#-10.1016\/j.bioorg.2024.107689_b0070.6","doi-asserted-by":"crossref","unstructured":"f) T. Goto, A. Shiina, T. Murata, M. Tomii, T. Yamazaki, K. Yoshida, T. Yoshino, O. Suzuki, Y. Sogawa, K. Mizukami, N. Takagi, T. Yoshitomi, M. Etori, H. Tsuchida, T. Mikkaichi, N. Nakao, M. Takahashi, H. Takahashi, S. Sasaki, Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors, Bioorg. Med. Chem. Lett. 24 (2014) 893-899","DOI":"10.1016\/j.bmcl.2013.12.076"},{"key":"#cr-split#-10.1016\/j.bioorg.2024.107689_b0070.7","doi-asserted-by":"crossref","unstructured":"g) T.J. Hagen, X. Mo, A.B. Burgin, D. Fox 3rd, Z. Zhang, M.E. Gurney, Discovery of triazines as selective PDE4B versus PDE4D inhibitors, Bioorg. Med. Chem. Lett. 24 (2014) 4031-4034.","DOI":"10.1016\/j.bmcl.2014.06.002"},{"key":"#cr-split#-10.1016\/j.bioorg.2024.107689_b0075.1","doi-asserted-by":"crossref","unstructured":"a) B. Sharma, R. Purohit, Structural insights into the lead identification of sub-type selective PDE4B inhibitors from plant bioactive molecule analogues, J. Mol. Liq. 390 (2023) 123039","DOI":"10.1016\/j.molliq.2023.123039"},{"key":"#cr-split#-10.1016\/j.bioorg.2024.107689_b0075.2","doi-asserted-by":"crossref","unstructured":"b) Y.-S. Li, X.-Y Liu, D.-S. Zhao, Y.-X. Liao, L.-H. Zhang, F.-Z. Zhang, G.-P. Song, Z-N. Cui, Tetrahydroquinoline and tetrahydroisoquinoline derivatives as potential selective PDE4B inhibitors, Bioorg. Med. Chem. Lett. 28 (2018) 3271-3275","DOI":"10.1016\/j.bmcl.2018.04.068"},{"key":"#cr-split#-10.1016\/j.bioorg.2024.107689_b0075.3","doi-asserted-by":"crossref","unstructured":"c) E.M. Louren\u00e7o, J.M. Fernandes, V.F. Carvalho, R. Grougnet, M.A. Martins, A.K. Jord\u00e3o, S. Zucolotto, E.G. Barbosa, Identification of a selective PDE4B inhibitor from Bryophyllum pinnatum by target fishing study and in vitro evaluation of quercetin 3-O-\u03b1-L-arabinopyranosyl-(1\u21922)-O-\u03b1-L-rhamnopyranoside, Front. Pharmacol. 10 (2019) 1582","DOI":"10.3389\/fphar.2019.01582"},{"key":"#cr-split#-10.1016\/j.bioorg.2024.107689_b0075.4","doi-asserted-by":"crossref","unstructured":"d) B. Purushothaman, P. Arumugam, J.M Song, A novel catecholopyrimidine based small molecule PDE4B inhibitor suppresses inflammatory cytokines in atopic mice, Front. Pharmacol. 9 (2018) 485.","DOI":"10.3389\/fphar.2018.00485"},{"key":"10.1016\/j.bioorg.2024.107689_b0080","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1021\/acs.jmedchem.9b02170","article-title":"Advances in the development of phosphodiesterase-4 inhibitors","volume":"63","author":"Peng","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107689_b0085","doi-asserted-by":"crossref","first-page":"1765633","DOI":"10.1080\/21688370.2020.1765633","article-title":"DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity","volume":"8","author":"Hunt","year":"2020","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.bioorg.2024.107689_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113514","article-title":"PdCl2-catalyzed synthesis of a new class of isocoumarin derivatives containing aminosulfonyl \/ aminocarboxamide moiety: First identification of a isocoumarin based PDE4 inhibitor","volume":"221","author":"Thirupataiah","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107689_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105265","article-title":"CuCl2-catalyzed inexpensive, faster and ligand\/additive free synthesis of isoquinolin-1(2H)-one derivatives via the coupling-cyclization strategy: Evaluation of a new class of compounds as potential PDE4 inhibitors","volume":"115","author":"Thirupataiah","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107689_b0100","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1055\/s-0042-115034","article-title":"Narciclasine \u2013 an Amaryllidaceae alkaloid with potent antitumor and anti-inflammatory properties","volume":"82","author":"F\u00fcrst","year":"2016","journal-title":"Planta Med."},{"key":"10.1016\/j.bioorg.2024.107689_b0105","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/cbdv.200690108","article-title":"Benzophenanthridine alkaloids from Zanthoxylum nitidum (Roxb.) DC, and their analgesic and anti-inflammatory activities","volume":"3","author":"Hu","year":"2006","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2024.107689_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103691","article-title":"Synthesis of 11,12-dihydro benzo[c]phenanthridines via a Pd-catalyzed unusual construction of isocoumarin ring\/FeCl3-mediated intramolecular arene-allyl cyclization: first identification of a benzo[c]phenanthridine based PDE4 inhibitor","volume":"97","author":"Thirupataiah","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107689_b0115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/bbrc.1997.6636","article-title":"Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D","volume":"234","author":"Wang","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2024.107689_b0120","doi-asserted-by":"crossref","first-page":"11518","DOI":"10.3390\/ijms241411518","article-title":"PDE4 inhibitors: profiling hits through the multitude of structural classes","volume":"24","author":"Jin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107689_b0125","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2024.107689_b0130","doi-asserted-by":"crossref","first-page":"D313","DOI":"10.1093\/nar\/gkw1132","article-title":"The SWISS-MODEL Repository-new features and functionality","volume":"45","author":"Bienert","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2024.107689_b0135","doi-asserted-by":"crossref","first-page":"E1414","DOI":"10.1073\/pnas.1419906112","article-title":"Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4","volume":"112","author":"Cedervall","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioorg.2024.107689_b0140","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1080\/07391102.2020.1780154","article-title":"Investigating the role of N-terminal domain in phosphodiesterase 4B-inhibition by molecular dynamics simulation","volume":"39","author":"Sharma","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2024.107689_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpc.2015.03.006","article-title":"Structural insight into the mechanism of amyloid precursor protein recognition by \u03b2-secretase 1: a molecular dynamics study","volume":"202","author":"Chakraborty","year":"2015","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bioorg.2024.107689_b0150","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bpc.2012.09.002","article-title":"Insight into estrogen receptor beta-beta and alpha-beta homo- and heterodimerization: a combined molecular dynamics and sequence analysis study","volume":"170","author":"Chakraborty","year":"2012","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bioorg.2024.107689_b0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nbt.1598","article-title":"Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety","volume":"28","author":"Burgin","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bioorg.2024.107689_b0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/0974-8490.172563","article-title":"UP1304, a botanical composition containing two standardized extracts of Curcuma longa and morus alba, mitigates pain and inflammation in adjuvant-induced arthritic rats","volume":"8","author":"Yimam","year":"2016","journal-title":"Pharmacognosy Res."},{"key":"10.1016\/j.bioorg.2024.107689_b0165","first-page":"262","article-title":"Systematic review of robust experimental models of rheumatoid arthritis for basic research, Digital","volume":"4","author":"Ye","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.bioorg.2024.107689_b0170","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.12752","article-title":"Daily oral administration of low-dose methotrexate has greater antirheumatic effects in collagen-induced arthritis rats","volume":"69","author":"Koyama","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107689_b0175","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bioorg.2024.107689_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108795","article-title":"3, 3\u2032- diindolylmethane hinders IL-17A\/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice","volume":"109","author":"Srikanth","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2024.107689_b0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.bioorg.2024.107689_b0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5826\/dpc.0503a02","article-title":"Diagnostic utility of Ki-67 and Cyclin D1 immunostaining in differentiation of psoriasis vs. other psoriasiform dermatitis","volume":"5","author":"Sezer","year":"2015","journal-title":"Dermatol. Pract. Concept."},{"key":"10.1016\/j.bioorg.2024.107689_b0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1051\/bmdcn\/2019090426","article-title":"Immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis","volume":"9","author":"Ramezani","year":"2019","journal-title":"Biomedicine (Taipei)"},{"key":"10.1016\/j.bioorg.2024.107689_b0200","doi-asserted-by":"crossref","first-page":"E3422","DOI":"10.1073\/pnas.1400513111","article-title":"IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms","volume":"111","author":"Ha","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioorg.2024.107689_b0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-\u03b1, IFN-y, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators Inflamm."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824005947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824005947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:47:03Z","timestamp":1781743623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824005947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":50,"alternative-id":["S0045206824005947"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107689","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting next-generation PDE4 inhibitors in search of potential management of rheumatoid arthritis and psoriasis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107689"}}